“Method Developed to Create and Purify Non-Toxic TDP-43 Oligomers That Retain RNA-Binding Ability for Potential Neurodegenerative Disease Treatments”

https://pubmed.ncbi.nlm.nih.gov/38116987

Researchers have developed a method to create and purify stable, non-toxic TDP-43 oligomers that retain their ability to bind RNA, which may lead to new approaches for halting TDP-43 aggregation in neurodegenerative diseases.